RT Journal Article
T1 In Vivo Selection of Fluoroquinolone-Resistant Escherichia coli Isolates Expressing Plasmid-Mediated Quinolone Resistance and Expanded-Spectrum β-Lactamase
T2 [In vivo selection of fluoroquinolone-resistant Escherichia coli isolates expressing plasmid-mediated quinolone resistance and expanded-spectrum beta-lactamase]
A1 Poirel, Laurent
A1 Pitout, Johann D.D.
A1 Calvo, Lucy
A1 Rodriguez-Martinez, Jose-Manuel
A1 Church, Deirdre
A1 Nordmann, Patrice
K1 Escherichia coli
K1 Plásmidos
K1 Secuencia de Bases
K1 Ciprofloxacino
K1 Conjugación Genética
K1 Farmacorresistencia Bacteriana
K1 Fluoroquinolonas
K1 Datos de Secuencia Molecular
K1 beta-Lactamasas
K1 Antiinfecciosos
AB A ciprofloxacin-resistant Escherichia coli isolate, isolate 1B, was obtained from a urinary specimen of a Canadian patient treated with norfloxacin for infection due to a ciprofloxacin-susceptible isolate, isolate 1A. Both isolates harbored a plasmid-encoded sul1-type integron with qnrA1 and blaVEB-1 genes. Isolate 1B had amino acid substitutions in gyrase and topoisomerase.
PB American Society for Microbiology
SN 0066-4804
YR 2006
FD 2006-04
LK http://hdl.handle.net/10668/1570
UL http://hdl.handle.net/10668/1570
LA en
NO Poirel L, Pitout JD, Calvo L, Rodriguez-Martinez JM, Church D, Nordmann P. In Vivo Selection of Fluoroquinolone-Resistant Escherichia coli Isolates Expressing Plasmid-Mediated Quinolone Resistance and Expanded-Spectrum β-Lactamase. [In vivo selection of fluoroquinolone-resistant Escherichia coli isolates expressing plasmid-mediated quinolone resistance and expanded-spectrum beta-lactamase]. Antimicrob. Agents Chemother. 2006; 50(4):1525-7
NO Journal Article; Research Support, Non-U.S. Gov't;
DS RISalud
RD Apr 19, 2025